Substituted quinazolines for inhibiting kinase activity
US-12403145-B2 · Sep 2, 2025 · US
Neupharma Inc holds 85 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 85 |
| Recent patents | 8 |
| First publication | Feb 26, 2015 |
| Latest publication | Sep 2, 2025 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12403145-B2 · Sep 2, 2025 · US
US-2024207256-A1 · Jun 27, 2024 · US
US-12018002-B2 · Jun 25, 2024 · US
US-2024197752-A1 · Jun 20, 2024 · US
US-2024116880-A1 · Apr 11, 2024 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12403145-B2 · Sep 2, 2025 · US
US-2024207256-A1 · Jun 27, 2024 · US
US-12018002-B2 · Jun 25, 2024 · US
US-2024197752-A1 · Jun 20, 2024 · US
US-2024116880-A1 · Apr 11, 2024 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 83 |
| A61K45/06 | 57 |
| C07D401/04 | 48 |
| A61K31/5377 | 46 |
| C07D403/04 | 41 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 85 |
| Chemistry & Metallurgy | 82 |
| Physics | 27 |
Answers are generated from the same data shown on this page.